Copy the page URI to the clipboard
Huzair, Farah and Kale, Dinar
(2015).
DOI: https://doi.org/10.1016/j.tibtech.2015.01.001
URL: http://www.sciencedirect.com/science/article/pii/S...
Abstract
Despite greater certainty for biosimilar markets and regulation, the change that was seen in the small-molecule pharmaceuticals market with the rapid entrance of emerging-country generics suppliers will not be replicated exactly. The long game has yet to be played out, and recent changes in regulation, science, and production technology are likely to impact on future patterns of partnership and production.
Viewing alternatives
Metrics
Public Attention
Altmetrics from AltmetricNumber of Citations
Citations from Dimensions- Published Version (PDF) This file is not available for public download
Item Actions
Export
About
- Item ORO ID
- 42557
- Item Type
- Journal Item
- ISSN
- 1879-3096
- Keywords
- biosimilars; health; India; pharmaceutical industry; follow-on biologic; subsequent entry biologic
- Academic Unit or School
-
Faculty of Science, Technology, Engineering and Mathematics (STEM) > Engineering and Innovation
Faculty of Science, Technology, Engineering and Mathematics (STEM)
Faculty of Arts and Social Sciences (FASS) > Social Sciences and Global Studies > Development
Faculty of Arts and Social Sciences (FASS) > Social Sciences and Global Studies
Faculty of Arts and Social Sciences (FASS) - Research Group
-
Innovation, Knowledge & Development research centre (IKD)
?? idii ??
Institute for Innovation Generation in the Life Sciences (Innogen) - Copyright Holders
- © 2015 Elsevier Ltd.
- Depositing User
- Dinar Kale